Luigi Banna G, Addeo A, Zygoura P, Tsourti Z, et al. A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9-15 PROMISE-meso phase III trial. Lung Cancer 2022;169:77-83.
PMID: 35660972